Patient Square Bets Big on NKTR: A Deep Dive for Investors
A prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
Understand the common budgeting problems and how to detect them quickly, with practical steps to verify numbers and correct course.
10,922 articlesA prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
A pre-retiree left for a rival firm and forfeited $74,000 in 401(K) employer matching by missing the vesting cliff. T...
The WHO has declared the latest ebola outbreak a public health emergency of international concern, prompting a wave o...
As markets shift in May 2026, experts remind investors that transferring retirement accounts between custodians is a ...
A 63-year-old faces a pivotal retirement choice: retire now or stay employed. With $480,000 saved and no pension, two...
As AI-driven data centers swell, electricity bills could rise in parts of the U.S. Utilities may lean on natural gas ...
With $2 million in retirement assets, some retirees may find LTC insurance less essential than once thought, as costs...
A major fund’s exit from Ocular Therapeutix raises questions about timing, liquidity, and sector signals. This articl...
When a hedge fund boosts its holdings, investors pay attention. This piece explains why Bridge City nearly tripled it...
SpaceX IPO chatter has investors itching for early exposure. This guide breaks down the smartest, legally sound ways ...
Big-name bets via 13F filings often reveal more about risk management than marketing hype. This quarter, billionaire ...
Healthcare often proves more resilient than broader markets. This guide highlights three durable healthcare ETFs and ...